Antigen- and/or immune-driven lymphoproliferative disorders
نویسندگان
چکیده
منابع مشابه
Antigen- and/or immune-driven lymphoproliferative disorders.
*Correspondence to: Mahmoud Aljurf, Department of Oncology and Laboratory of Tumor Immunology, King Faisal Specialist Hospital & Research Center, MBC 64, PO Box 3354, Riyadh 11211, Saudi Arabia. Tel: +966-1-442-3937; Fax: +966-1-442-3941; E-mail: [email protected] Departments of Oncology and Pathology & Laboratory of Medicine, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Ar...
متن کاملImmune thrombocytopenia in lymphoproliferative disorders.
Lymphoproliferative disorders are recognized as a common cause of secondary immune thrombocytopenia (ITP). The mechanisms involved in the pathogenesis of ITP associated with lymphoproliferative disorders are heterogeneous and often linked to the presence and activity of the malignant clone. A better understanding of the responsible mechanisms leading to ITP in each disease may allow for targete...
متن کاملHiv-Related Lymphoproliferative Disorders
Lymphoproliferative disorders including non-Hodgkin lymphomas (NHL) are not uncommon neoplasms in patients infected with the human immunodeficiency virus (HIV). It has been established that HIV-infected individuals are more prone to develop certain lymphoproliferative disorders and lymphomas compared to non-infected individuals. The exact mechanisms underlying these associations is yet to be es...
متن کاملPosttransplant Lymphoproliferative Disorders
Posttransplant lymphoproliferative disorders (PTLDs) are a group of diseases that range from benign polyclonal to malignant monoclonal lymphoid proliferations. They arise secondary to treatment with immunosuppressive drugs given to prevent transplant rejection. Three main pathologic subsets/stages of evolution are recognised: early, polymorphic, and monomorphic lesions. The pathogenesis of PTLD...
متن کاملCD30+ lymphoproliferative disorders.
27. Thol F, Weissinger EM, Krauter J, Wagner K, Damm F, Wichmann F, et al. IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis. Haematologica 2010;95(10):1668-74. 28. Kosmider O, Gelsi-Boyer V, Slama L, Dreyfus F, Beyne-Rauzy O, Quesnel B, et al. Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and M...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2003
ISSN: 0923-7534
DOI: 10.1093/annonc/mdg442